Medical News

RSS

APP Pharmaceuticals receives FDA approval to market Aztreonam for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.

21 Jun 2010

Obese women with insulin resistance lose more weight on lower-carbohydrate diet: Study

Obese women with insulin resistance lose more weight after three months on a lower-carbohydrate diet than on a traditional low-fat diet with the same number of calories, according to a new study. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego.

21 Jun 2010

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Children exposed to polychlorinated biphenyls early in life later had a diminished immune response to diphtheria and tetanus vaccinations, according to a study published online June 20 ahead of print in the peer-reviewed journal Environmental Health Perspectives. This result suggests that PCB exposure during the first years of life, a critical period in immune system development, could undermine the effectiveness of childhood vaccinations and possibly impair immune system responses to infection.

21 Jun 2010

Exelixis announces regaining of rights to develop and commercialize XL184

Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.

21 Jun 2010

Studies explore effects of fructose consumption on metabolic parameters in humans

New research released today from Rippe Lifestyle Institute and the University of Central Florida shows no difference between table sugar and high fructose corn syrup on weight gain or any changes in risk factors for metabolic syndrome or insulin resistance, a precursor to diabetes. Abstracts for the two studies are the first to provide longer term prospective data exploring the effects the normal consumption of fructose has on metabolic parameters in humans.

21 Jun 2010

Picking right soundtrack could improve getting a date, suggest French researchers

If you're having trouble getting a date, French researchers suggest that picking the right soundtrack could improve the odds. Women were more prepared to give their number to an 'average' young man after listening to romantic background music, according to research that appears today in the journal Psychology of Music, published by SAGE.

21 Jun 2010

State leaders to increase New York cigarette tax by $1.60 per pack

It is great news for New York's health that state leaders are planning to increase the state cigarette tax by $1.60 per pack, while also increasing the tax on other tobacco products and ensuring that taxes are properly paid on cigarettes sold by Native American tribes to non-tribal members. Increasing the tobacco tax is one of the most effective ways to reduce smoking and other tobacco use, especially among children.

21 Jun 2010

Government's COE Program encourages research activities in universities across Japan: Study

Scopus- announced today that Kyoto University is employing the former's data and functions in a study performed by Dr. Takanori Ida, Professor at the Graduate School of Economics - Kyoto University. The study shows how effectively the government's large funding scheme, 21st Century Center of Excellence Program, encouraged research activities in universities across Japan.

21 Jun 2010

Achieving remission in patients lessens burden of RA on societies with aging populations: Study

Achieving disease remission in patients with rheumatoid arthritis provides superior outcomes across measures of socio-economic importance including work productivity and quality of life according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. These Austrian findings are reported in addition to improvements in measures of physical functioning, when compared with RA patients achieving low disease activity.

21 Jun 2010

Study examines ability of organisms to survive, sustain against various infectious diseases

"Robust" is an adjective appreciatively applied to certain vintage wines, but when describing viruses and pathogens, robustness is a property that may be much less desirable. It evokes drug resistant microbes and other superbugs that can wreak havoc as researchers struggle to deal with new pandemics. How can we undercut this robustness?

21 Jun 2010

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.

21 Jun 2010

Thomson Reuters' The Outpartnering Registry available for all organizations developing drugs

Thomson Reuters announced today that it has launched The Outpartnering Registry, an innovative resource designed to change the way biotechnology, pharmaceutical and academic organizations find partnering opportunities around the world.

21 Jun 2010

SAGE launches new online resource to spotlight on research published across scholarly journals

Leading academic and professional publisher SAGE today announced the launch of a new online resource that will put the spotlight on research published across its scholarly journals.

21 Jun 2010

PAS technique to predict how blood platelets respond to complex conditions found during heart attack

A team of bioengineers from the University of Pennsylvania Institute for Medicine and Engineering have trained a computer neural network model to accurately predict how blood platelets would respond to complex conditions found during a heart attack or stroke.

21 Jun 2010

Prototype drug blocks MCL-1 protein that helps tumors survive treatment: Scientists

Scientists at Dana-Farber Cancer Institute have found a way to disable a common protein that often thwarts chemotherapy treatment of several major forms of cancer.

21 Jun 2010

CORD:USE plans to open family cord blood bank

CORD:USE Cord Blood Bank, a public cord blood banking facility, and its Team of cord blood pioneers and leaders announced last month their plans to open a family cord blood bank to offer its high quality services to new parents who elect to privately bank their baby's cord blood. The Team of experts in cord blood biology, banking and transplantation includes Drs. Hal Broxmeyer, Joanne Kurtzberg, John Wagner, Eliane Gluckman and Alan Levine.

21 Jun 2010

Father's Day: CHMC releases new resources for fathers

"The most important thing a father can do for his child is to love their mother," said theologian Theodore M. Hesburgh. With Father's Day at the forefront of everyone's minds, California Healthy Marriages Coalition (CHMC) has released new resources for fathers.

21 Jun 2010

Magic Power Coffee can dangerously lower blood pressure, warns FDA

The U.S. Food and Drug Administration is warning consumers that Magic Power Coffee, an instant coffee product marketed as a dietary supplement for sexual enhancement, contains an active drug ingredient that can dangerously lower blood pressure.

21 Jun 2010

European drug companies' lead in making medicines available to developing countries shrinking: Report

European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.

21 Jun 2010

Metabolically healthy obese people appear to have protection against cardiovascular disease: Study

Obese people without metabolic risk factors for diabetes and heart disease, such as high blood pressure and cholesterol, do not have the elevated cardiovascular risk typical of obesity, but they represent only a small percentage of the obese population, according to a long-term study. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego

21 Jun 2010

Medical News

APP Pharmaceuticals receives FDA approval to market Aztreonam for Injection, USP

Obese women with insulin resistance lose more weight on lower-carbohydrate diet: Study

Early-life exposure to PCBs diminishes immune response to diphtheria and tetanus vaccinations: Study

Exelixis announces regaining of rights to develop and commercialize XL184

Studies explore effects of fructose consumption on metabolic parameters in humans

Picking right soundtrack could improve getting a date, suggest French researchers

State leaders to increase New York cigarette tax by $1.60 per pack

Government's COE Program encourages research activities in universities across Japan: Study

Achieving remission in patients lessens burden of RA on societies with aging populations: Study

Study examines ability of organisms to survive, sustain against various infectious diseases

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Thomson Reuters' The Outpartnering Registry available for all organizations developing drugs

SAGE launches new online resource to spotlight on research published across scholarly journals

PAS technique to predict how blood platelets respond to complex conditions found during heart attack

Prototype drug blocks MCL-1 protein that helps tumors survive treatment: Scientists

CORD:USE plans to open family cord blood bank

Father's Day: CHMC releases new resources for fathers

Magic Power Coffee can dangerously lower blood pressure, warns FDA

European drug companies' lead in making medicines available to developing countries shrinking: Report

Metabolically healthy obese people appear to have protection against cardiovascular disease: Study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News